Untitled Document Home
Chef & Hotel Profile
Publisher's Page
Gift Guide
Travel Adventures
Epicurean Events
Health Minded
Spa Baby Secrets
Sips
Book Bites
Culinary Coup
Sense of Style
Kids Kaleidoscope
Tinsletown Tidbits
Wheels
Radio Show & Links
Contact Us


POPE FRANCIS SPEAKS ON GREATEST DANGERS TO FACE

On the greatest challenges for the church:

“The most serious of the evils that afflict the world these days are youth unemployment and the loneliness of the old. The old need care and companionship; the young need work and hope but have neither one nor the other, and the problem is they don’t even look for them any more. They have been crushed by the present. You tell me: Can you live crushed under the weight of the present? Without a memory of the past and without the desire to look ahead to the future by building something, a future, a family? Can you go on like this? This, to me, is the most urgent problem that the Church is facing.”

__________________________________________________________________                                                                                                                                                                        University of California Santa Barbara and H. Zisser, Sansum Diabetes Research Institute - Postprandial blood glucose control during an artificial pancreas study after a meal containing 50 grams carbohydrate with and without ultra-rapid-acting inhaled insulin. Graphic: The Doyle Group. 

Sansum Diabetes Research Institute, University of California, Santa Barbara Conduct Innovative Artificial Pancreas – Ultra-Rapid-Acting Inhaled Insulin Trial Funded by JDRF

JDRF, Sansum Diabetes Research Institute, and the College of Engineering at University of California, Santa Barbara (UCSB) are pleased to announce the first successful clinical research trial using the artificial pancreas in conjunction with ultra-rapid-acting inhaled insulin. This represents a groundbreaking potential advancement in the treatment of type 1 diabetes (T1D). It establishes that the disease can be managed through a unified automated process that delivers precise amounts of insulin around the clock, based on real-time glucose measurements without the need for patient intervention, and is further enhanced and fine-tuned by the swift delivery of ultra-rapid-acting inhaled insulin during mealtimes. The artificial pancreas and inhaled insulin system work together to replicate the normal, healthy function of the human pancreas. This combination therapy has the ability to greatly improve the regulation of prandial and postprandial blood glucose levels. This research is funded by JDRF, the world‟s largest non-profit supporter of T1D research.

Sansum Diabetes is the only site testing ultra-rapid-acting inhaled insulin in combination with the artificial pancreas. Principal investigator Howard Zisser, M.D., director of research and technology at Sansum Diabetes, acknowledged that "This study addresses one of the big questions in diabetes research, which is, „How do we manage meals with the artificial pancreas?‟" He went on to point out, "The JDRF, Sansum Diabetes, and UCSB consortium has spent the past five years developing several approaches to an artificial pancreas to automate insulin delivery for patients with type 1 diabetes to improve glucose control throughout the day and overnight. JDRF recognizes that we can use technology to help improve the lives of people with type 1 diabetes until there is a cure."

As for this innovative study, Dr. Zisser stated: "Our preliminary results on the artificial pancreas working in tandem with the administration of mealtime ultra-fast-acting inhaled insulin are most promising. It's very straightforward to load the inhaler device and take the insulin. There's no needle involved and the small dose of inhaled insulin prevents the blood glucose from uprising very quickly just after eating or falling too fast an hour or two later. In this way, the subcutaneous insulin being supplied by the artificial pancreas‟ pump has the chance to actually work better."

Co-principal investigator Francis J. Doyle, III, professor of chemical engineering, Mellichamp chair in process control, and associate dean of research at UCSB explained that "The subcutaneous route of delivery is a very slow way to push insulin into the body, compared to the appearance of glucose in the blood stream following the meal. So we need a much quicker way to intervene. One way to do that is to dose with the pump, but again, you‟re using a subcutaneous route of pushing insulin, which is slow compared to the way the pancreas would do this. So, by using inhaled, ultra- rapid-acting insulin, we have a chance now to manage blood glucose even better by emulating a more natural pancreatic function. We can get the insulin quickly into circulation and it will be cleared quickly and safely from the bloodstream."

Aaron Kowalski, Ph.D., vice president of treatment therapies at JDRF, remarked that "The early results of this exciting study are compelling. While more data are required, this protocol represents a potentially revolutionary way of combining the artificial pancreas with a simple-to-use inhaled insulin to significantly improve blood sugar levels. We are excited that Sansum Diabetes and UCSB researchers are working together with us and continuing to push the frontiers of diabetes research forward to benefit the quality of life for people living with the disease."

About Sansum Diabetes Research Institute

Sansum Diabetes Research Institute is an internationally recognized research center devoted to the prevention, treatment and cure of diabetes. Dr. William D. Sansum, who brought renown to Santa Barbara in 1922 as the first physician in the U.S. to produce and administer life-saving insulin to patients with diabetes, founded the nonprofit organization in 1944.

The Institute has gained global acclaim for its work to develop an artificial pancreas, its success in developing protocols to increase the incidence of healthy babies born to women with diabetes, and its work with people with and at risk for type 2 diabetes. Physicians and researchers continue to develop new treatment protocols for people with diabetes, including new drugs and medical devices.

It is our intention to use our past and present accomplishments to guide us into the future – to tap into the energy and commitment that made Sansum Diabetes Research Institute what it is today – a worldwide leader in diabetes research, education and care. For more information, please visit www.sansum.org

About the College of Engineering, University of California, Santa Barbara

The College of Engineering at UC Santa Barbara is dedicated to educating the next generation of engineering and science leaders to discover and apply breakthroughs in knowledge and technology. UCSB Engineering is recognized globally as a leader among the top tier of engineering education and research programs. Our programs are ranked consistently among the most prestigious Engineering institutions in the world.

UCSB Engineering is renowned in the areas of materials, electrical engineering, photonics, solid state lighting, bioengineering, nanotechnology, chemical engineering, computer science, and mechanical engineering. For more information about the Doyle Group‟s research, please visit http://thedoylegroup.org/biomedical-control/

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF‟s goal is to progressively remove the impact of T1D from people‟s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.

As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF‟s expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization‟s efficiency and effectiveness.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


2008
March 08 | April 08 | May 08 | June 08 | July 08 | July 080 | September 08 | October 08 | November 08 | December 08 | January 09 | February 09 | March 09 | April 09 | May 09 | June 09 | July 09 | August 09 | September 09 | October 09 | November 09 | December 09 | January 10 | February 10 | March 10 | April 10 | May 10 | June 10 | July 10 | August 10 | September 10 | October 10 | November 10 | December 10 | January 11 | February 11 | March 11 | April 11 | May 11 | June 11 | July 11 | August 11 | September 11 | October 11 | November 11 | December 11 | January 12 | February 12 | March 12 | April 12 | May 12 | June 12 | June | July 12 | August 12 | September 12 | October 12 | November 12 | December 12 | January 13 | February 13 | March 13 | April 13 | May 13 | June 13 | July 13 | August 13 | September 13 | October 13 | November 13 | December 13 | December | January 14 | February 14 | March 14 | April 14 | May 14 | June 14 | July 14 | August 14 | September 14 | October 14 | December 14 | November 14 | January 15 | February 15 | March 15 | April 15 | May 15 | July 15 | June 15 | August 15 | September 15 | October 15 | November 15 | December 15 | January 16 | February 16 | March 16 | April 16 | May 16 | August 16 | September 16 | June 16 | July 16 | October 16 | November 16 | December 16 | January 17 | February 17 | March 17 | April 17 | May 17 | June 17 | July 17 | August 17 | September 17 | January 18 | October 17 | November 17 | December 17 | February 18 | March 18 | April 18 | May 18 | June 18 | July 18 | August 18 | September 18 | October 18 | November 18 | December 18 | January 19 | February 19 | March 19 | April 19 | May 19 | June 19 | July 19 | August 19 | September 19 | October 19 | November 19 | December 19 | January 20 | February 20 | March 20 | April 20 | May 20 | June 20 | July 20 | August 20 | September 20 | October 20 | November 20 | December 20 | January 21 | February 21 | March 21 | April 21 | May 21 | June 21 | July 21 | August 21 | September 21 | October 21 | November 21 | December 21 | January 22 | February 22 | April 22 | March 22 | May 22 | June 22 | July 22 | August 22 | September 22 | September 22 | October 22 | November 22 | December 22 | January 23 | February 23 | February 23 | March 23 | April 23 | May 23 | June 23 | July 23 | August 23 | September 23 | October 23 | November 23 | December 23 | January 24 | February 24 | March 24 | April 24 | May 24 | June 24 | July 24 | August 24 | September 24 | February 08 | January 08

2007
December 07
| November 07 | October 07 | September 07 | August 07 | July 07 | June 07 | May 07
April 07 | March 07 | February 07 | January 07

2006
December 06
| November 06 | October 06 | September 06 | August 06 | July 06 | June 06 | May 06
April 06 | March 06 | February 06 | January 06

2005
December 05
| November 05 | October 05 | September 05 | August 05 | July 05 | June 05 | May 05
April 05
| March 05 | February 05 | January 05

© 2008 Bonnie Carroll, All Rights Reserved